Clinical Development Director
Enveda
Summary
As a Clinical Development Director at Enveda, you'll write the protocols and lead the studies for our first-in-class oral medicines, hands-on and across indications. Your role is within immuno-inflammation and will include inflammatory bowel disease, and the role is built to work across indications as the pipeline needs. You'll report to the SVP of Clinical Development, and work day to day with the Global Program Heads, Clinical Operations, and the medical monitors.
Job description
Your Role
As a Clinical Development Director at Enveda, you'll write the protocols and lead the studies for our first-in-class oral medicines, hands-on and across indications. Your role is within immuno-inflammation and will include inflammatory bowel disease, and the role is built to work across indications as the pipeline needs. You'll report to the SVP of Clinical Development, and work day to day with the Global Program Heads, Clinical Operations, and the medical monitors.
What You'll Do
- Own your studies end to end as their clinical lead, from protocol through start-up and enrollment
- Write protocols and the clinical sections of regulatory documents yourself, making the study-level design calls and bringing endpoint, population, and go/no-go options to the Global Program Head with a recommendation
- Work with Clinical Operations to hold CROs, sites, and vendors to timelines, enrollment, budget, and data quality, as the clinical voice in those conversations
- Review blinded safety, PK, and operational data with the medical monitor and act on what it shows
- Be flexible across decisions and across indications, collaborating and learning at speed as you move into new areas
- Take on a study in a second indication when the pipeline needs it and get up to speed fast
- Use AI every day in your own work to support you and build new ways of working, then share what works with the team
- Build relationships with investigators, sites, and KOLs that make studies run well and designs stronger
- Bring the patient's perspective into every consequential decision
What We're Looking For
- An advanced degree (MD, DO, PhD, PharmD, or equivalent). Physicians and clinical scientists are equally welcome
- Hands-on clinical development experience: you have written protocols as primary author and taken at least one study from protocol to database lock as its lead (typically 8+ years for a clinical scientist, or 3+ years in industry after clinical training for a physician)
- Clinical or trial experience in inflammatory bowel disease, ideally with endoscopic endpoints and central reading (preferred, not required)
- Experience in a second therapeutic area
- Data-driven judgment: you turn clinical, safety, and operational data into clear decisions and change course when the data says to
- AI-native or AI-ready: you are keen to learn, or already know how to, draft, check, and interrogate your own work with AI, and are aware of where it can mislead you
- Ego-lite, high agency, and patient-first: collaborative, direct, no task too big or small, and never losing sight of who the trial is for
Requirements
- Advanced degree (MD, DO, PhD, PharmD, or equivalent)
- Hands-on clinical development experience
- Written protocols as primary author
- Taken at least one study from protocol to database lock as its lead
- Typically 8+ years for a clinical scientist, or 3+ years in industry after clinical training for a physician
- Clinical or trial experience in inflammatory bowel disease (preferred)
- Experience with endoscopic endpoints and central reading (preferred)
- Experience in a second therapeutic area
- Data-driven judgment
- AI-native or AI-ready
- Ego-lite, high agency, and patient-first
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Flexible PTO
- Company-wide recharge break
- Adoption Assistance
Company overview
Enveda is an innovative biotechnology company that leverages artificial intelligence and natural product chemistry to accelerate drug discovery. Founded in 2019 and headquartered in Boulder, Colorado with operations in Hyderabad, India, Enveda has developed a proprietary platform that reads and translates nature's hidden chemistry at unprecedented speed and scale. The company's approach focuses on identifying and characterizing molecules produced by living organisms, creating what they call 'the library of life' - a database of chemical biodiversity that represents billions of years of evolutionary intelligence. By combining AI-powered tools with metabolomics expertise, Enveda aims to discover medicines four times faster than the industry average. The company has already advanced multiple drug candidates into clinical development, including ENV-294 for atopic dermatitis, demonstrating their ability to rapidly translate natural product discoveries into therapeutic candidates. With a team of 201-500 employees and recent unicorn status achieved through a $150 million Series D funding round, Enveda represents a new generation of biotech companies integrating advanced technology with nature's evolved chemistry to address pressing medical needs.